# FDA Inspection 1181891 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - September 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/33ac34b8-0200-4357-bc2a-e2425a7a2bad
Source feed: FDA_Inspections

> FDA Inspection 1181891 for SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) on September 20, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181891
- Company Name: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
- Inspection Date: 2022-09-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1233707 - 2024-03-15](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/064ffa75-823f-4b4a-ac70-4da31c81faa0)
- [FDA Inspection 1101506 - 2019-07-05](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/63db143a-b785-4875-96d0-efc0ded378e0)
- [FDA Inspection 1019795 - 2017-06-27](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/e4847276-f3f0-4073-a7d2-e60f6d62c3c5)
- [FDA Inspection 736162 - 2011-06-22](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/9bd6598d-06ea-4432-a764-dfef23c024fb)
- [FDA Inspection 668686 - 2010-05-24](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/49014175-4fa2-49ea-bcf4-5a95e1454b0d)

Company: https://www.keypedia.com/companies/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/184bcdd6-8f25-45bf-b562-fcb41f6c48f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d